On the topic of drug resistance, if Relenza reaches wider spread use it is inevitable that resistant strains will develop towards it as well. We are perhaps some years off from this happening, but it's something to keep in mind as investors.
BTA Price at posting:
$2.61 Sentiment: Buy Disclosure: Held
